StockData
Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc. (CRVS) stock

CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$10.17−0.43 (-4.06%)

Close on Nov 17, 2026Market cap $855.51MP/E –Yield –

Corvus Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Corvus Pharmaceuticals's market cap was $964.87M on Nov 11, 2026, against $684.83M a year earlier. Over the last 5 years it ranged from $33.98M to $1.55B, with a median of $126.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$964.87M+67.8%
2025Dec 31, 2025$575.05M+71.8%
2024Dec 31, 2024$334.80M+287.9%
2023Dec 29, 2023$86.31M+118.1%
2022Dec 30, 2022$39.57M-64.7%
2021Dec 31, 2021$112.18M+12.3%
2020Dec 31, 2020$99.89M-37.6%
2019Dec 31, 2019$159.97M+48.9%
2018Dec 31, 2018$107.47M-50.5%
2017Dec 29, 2017$216.98M-27.4%
2016Dec 30, 2016$299.04M–

More Corvus Pharmaceuticals figures

See a number that looks wrong?